Hepion pharmaceuticals' rencofilstat demonstrates anti-cancer activity in hepatitis c-associated cancer model

- rencofilstat, but not sofosbuvir or velpatasvir, significantly suppressed tumor growth - - rencofilstat, but not sofosbuvir or velpatasvir, significantly suppressed tumor growth -

HEPA Ratings Summary

HEPA Quant Ranking